# Akso-biotech.com

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/akso-biotech-com

- Industry: Biotechnology
- Headquarters: Suzhou, China
- Website: www.akso-biotech.com
- Total disclosed funding: $3.1M
- Latest round: Angel (Apr 12, 2022)
- Investors on record: 1

## About

Based in Suzhou, China, and established in 2021, Akso-biotech.com is a biotechnology company that focuses on R&D and production of microspheres' products take the technology of high throughput microfluidic technology. The three founders of the company are from the Department of Materials and Bioengineering, Tsinghua University. The company's co-founder, Jiake Chen, graduated from Tsinghua University and holds 20 patents. As of 2024, this company has established a 1,600-square-meter R&D lab, more than 40 R&D staff, and more than 10 microsphere pipelines. In April 2024, it closed a pre-series A funding.

The company provides microspheres products that are nanoscale spherical particles. Specific products include chromatography filler materials, affinity filler materials, ion-exchange filler materials, hydrophobic fillers materials, and volumetric drainage filler materials. Those products can be applied for the separation and purification of biopharmaceuticals, and carriers for sustained drug release.

The company will use the pre-series A funding for technology platform and 3D microfluidic chip R&D, production line construction, and market expansion.

## Funding rounds

- Angel, Apr 12, 2022, $3.1M — Vitalbridge Capital

## Investors

- Vitalbridge Capital — Angel